Description :
- eating disorder characterized by restrictive eating to the point of self-starvation, severe self-induced weight loss
ICD-9 Codes :
ICD-10 Codes :
- F50.0 anorexia nervosa
- F50.1 atypical anorexia nervosa
- F50.8 other eating disorders
- F50.9 eating disorders, unspecified
Types :
- binge-purge subtype -- may use laxatives, vomiting, diuretics to achieve weight loss
- restricting subtype -- patients limit their intake of food to lose weight
Who is most affected :
- female
- peaks in adolescence
- family history of eating disorders
- case report of anorexia nervosa in adolescent male can be found in Child Psychiatry Hum Dev 1990 Winter;21(2):79
- anorexia nervosa may exist in various cultures
- based on study of 668 students in Ghana
- 10 women with body mass index < 17.5 kg/m 2 had "self starvation" as only cause
- reasons were not based on weight or shape but these students had beliefs about self control and hunger denial that were viewed positively toward food restriction and in religious terms
- Reference - Br J Psychiatry 2004 Oct;185:312 full-text
- discussion of eating disorders in Asian populations can be found in Am J Orthopsychiatry 2005 Oct;75(4):553
Incidence/Prevalence :
- 1.2% women and 0.29% men had anorexia nervosa among Swedish twins
- based on prospective study of 31,406 persons born 1935-1958 in Swedish Twin Registry
- prevalence higher in persons born after 1945
- heritability estimated to account for 56% cases
- Reference - Arch Gen Psychiatry 2006 Mar;63(3):305
- 2.2% lifetime prevalence of anorexia nervosa among female Finnish twins
- based on study of 2,881 women born 1975-1979 in Finnish twin cohort
- incidence of anorexia nervosa in women aged 15-19 years was 270 per 100,000 person-years
- Reference - Am J Psychiatry 2007 Aug;164(8):1259
- weight concerns common among young adolescents
- based on survey of 2,331 young adolescents (grades 6-8)
- 23.8% considered themselves overweight
- 45% trying to lose weight
- 34% dieting
- 59.4% exercising to lose or maintain weight
- 6.7% vomiting or taking laxatives
- 6.8% taking diet pills
- Reference - Arch Pediatr Adolesc Med 1998 Sep;152(9):884 in Pediatric Notes 1998 Oct 15;22(42):166
- in study of Australian school children (888 girls and 811 boys) ages 14-15 years at beginning of study and followed 3 years
Likely risk factors :
- early warning signs
- persistent dieting
- arrest in weight gain during puberty
- social isolation
- compulsive exercise
- preoccupation with thinness and body image
- genetic risk factors reported with linkage regions on chromosomes 1,3, and 4 for anorexia nervosa (Am J Pharmacogenomics 2004;4(4):209)
- risk factors for development of eating disorders include dieting and psychiatric co-morbidity
- perfectionism and negative self-evaluation are common precedents to anorexia nervosa
Possible risk factors :
- perinatal factors (cephalhematoma, very preterm birth, small for gestational age) associated with increased risk for anorexia nervosa
- based on population-based study with 781 girls ages 10-21 years with anorexia nervosa and 3,905 controls matched by year and hospital of birth
- Reference - Arch Gen Psychiatry 1999 Jul;56(7):634
- DynaMed commentary -- not clear that confounding risk factors were accounted for
- diabetes mellitus type 1 associated with increased risk for eating disorders
- based on comparison of 356 Canadian females aged 12-19 years with type 1 diabetes vs. 1,098 age-matched non-diabetic controls
- comparing girls with diabetes vs. controls
- 10% vs. 4% had eating disorders that met DSM-IV criteria (p < 0.001)
- 14% vs. 8% had subthreshold eating disorders (p < 0.001)
- Reference - BMJ 2000 Jun 10;320(7249):1563 full-text
- eating alone may be a risk factor for developing eating disorders
- based on study of 2,862 girls aged 12-21 years
- patients were evaluated twice 18 months apart with 90 (3%) developing eating disorders during follow-up
- risk factors for incident eating disorder were
- younger age
- usually eating alone
- frequently reading girls' magazines and listening to radio programs
- parents not being married
- Reference - Pediatrics 2003 Feb;111(2):315 full-text, commentary can be found in Evid Based Nurs 2003 Oct;6(4):120
- < 5 family meals weekly associated with increased risk of disordered eating in girls and unhealthy weight control behaviors in boys
- based on observational study
- 2,516 adolescents surveyed regarding family meal frequency and surveyed for disordered eating behaviors 5 years later
- comparing girls having < 5 meals vs. ≥ 5 meals weekly with family
- extreme weight control behaviors (self-induced vomiting and use of laxatives, diet pills, or diuretics) in 26% vs. 17% (p < 0.001)
- unhealthy weight control behaviors (eating very little, fasting, using food substitutes, skipping meals, or smoking) in 64.4% vs. 57.4% (p = 0.008)
- binge eating in 12.7% vs. 9.2% (p = 0.046)
- chronic dieting in 18.5% vs. 13.9% (p = 0.02)
- in boys
- unhealthy weight control behaviors in 29% boys having < 5 family meals weekly vs. 35.4% boys having ≥ 5 family meals weekly (p = 0.02)
- no significant differences with number of family meals on extreme weight control behaviors, binge eating and chronic dieting
- Reference - Arch Pediatr Adolesc Med 2008 Jan;162(1):17
Complications :
- increased mortality and suicide risk, especially if severe alcohol use disorder
- based on prospective study of 246 women with anorexia nervosa (136) or bulimia nervosa (110)
- 11 women (4.5%) died over 4 years
- anorexia nervosa associated with 7.4% crude mortality
- anorexia nervosa associated with increased standardized mortality ratios for all causes (11.6) and suicide (56.9)
- severity of alcohol use disorder predicted mortality
- history of hospitalization for affective disorder associated with reduced mortality
- Reference - Arch Gen Psychiatry 2003 Feb;60(2):179
- cardiac complications
- sudden death - ventricular arrhythmias (especially ventricular tachycardia if prolonged QT), sinus arrest
- mitral valve prolapse may be reversible complication of anorexia nervosa
- caused by ventriculovalvular disproportion due to starvation-induced myocardial atrophy and intravascular volume depletion
- myxomatous degeneration of mitral valve may disappear with refeeding
- Reference - letter in Am Fam Physician 1997 Jul;56(1):52
- DynaMed commentary -- mitral valve prolapse may be overdiagnosed in thinner patients
- review of cardiac effects of anorexia nervosa can be found in Int J Eat Disord 1995 May;17(4):313
- osteoporosis
- increased fracture risk persists long-term after diagnosis of anorexia nervosa
- based on retrospective cohort study
- 193 women and 15 men first diagnosed with anorexia nervosa between 1935-1989 had 2,689 person-years of follow-up
- 45 patients developed 88 fractures which was substantially higher than expected numbers of fractures
- fractures of hip, spine and forearm were late complications
- 57% cumulative incidence of any fracture at 40 years after diagnosis of anorexia nervosa
- Reference - Mayo Clin Proc 1999 Oct;74(10):972
- in 130 women (mean age 24 years) with anorexia nervosa, 47-57% had osteopenia (depending on site measured), 13-24% had osteoporosis and 26% had history of fracture (Ann Intern Med 2000 Nov 21;133(10):790 PDF), editorial can be found in Ann Intern Med 2000 Nov 21;133(10):828 PDF, commentary can be found in Ann Intern Med 2001 Nov 6;135(9):843
- history of anorexia nervosa not associated with adverse birth outcomes
- based on prospective cohort study of all 837,582 primiparous women who gave birth in Sweden 1983-2002
- 1,000 women with history of hospital discharge with diagnosis of anorexia nervosa compared to 827,582 controls without such history
- no significant differences between groups for perinatal mortality, prematurity, birthweight, Apgar score, size for gestational age, pre-eclampsia, instrumental delivery
- Reference - BJOG 2006 Aug;113(8):925
- during pregnancy, women with eating disorders may be more likely to have anemia and hyperemesis and deliver infants with lower mean birth weight and smaller head circumference
- based on 49 pregnant women with history of eating disorder compared with 68 controls
- comparing women with history of eating disorder vs. controls
- 8 vs. 0 had infant with microcephaly (p < 0.05)
- 12 vs. 1 had small for gestational age infant (p < 0.05)
- Reference - Obstet Gynecol 2005 Feb;105(2):255 in J Watch Online 2005 Mar 4
- end organ damage from malnutrition (liver, brain, kidney, skin, pancreas)
- metabolic disturbances - hypokalemia, hypothermia, endocrinopathy
- cognitive changes, depression
- infertility
- growth retardation reported in 11 of 12 male adolescents with anorexia nervosa (Pediatrics 2003 Feb;111(2):270 full-text)
- refeeding syndrome with profound hypophosphatemia, editorial review can be found in BMJ 2004 Apr 17;328(7445):908 full-text
- high prevalence of hemodynamic, hematologic, endocrine, and bone density abnormalities reported in group of 60 adolescent girls with anorexia nervosa treated as outpatients (Pediatrics 2004 Dec;114(6):1574 full-text), commentary can be found in Am Fam Physician 2005 Oct 1;72(7):1353
Associated conditions :
- bulimia
- depression
- common comorbid conditions in 40 women with anorexia nervosa
- other anxiety disorders
- associated medical findings in series of 214 women aged 17-45 years with anorexia nervosa included
Chief Concern (CC) :
- typically patient is brought to attention of caregiver by relative or friend concerned about severe weight loss and malnutrition
- fatigue (ominous sign)
- pre-menarchal girls with eating disorder have height and weight deficits in growth charts long before weight loss, based on review of growth charts of 45 such girls (Acta Paediatr 2003 Oct;92(10):1133)
History of Present Illness (HPI) :
- weight loss of 15% ideal body weight
- amenorrhea for 3 consecutive months
- intense fear of being/becoming obese
- disturbed body image (often of delusional proportion)
- persistent desire to lose weight despite emaciation
- excessive exercise may be common component of or warning sign of anorexia nervosa
- based on interviews of hospitalized eating disordered patients
- 78% of patients had excessive exercise
- 60% were competitive athletes prior to onset of eating disorder
- 75% had steady increase in exercise during period of maximal decrease in food intake and weight
- Reference - Psychol Med 1994 Nov;24(4):957
- may be associated with purging behavior, laxative or diuretic abuse, ipecac ingestion
- record extensive dietary history, chronology of weight loss including maximum weight and rate of weight loss
Medication History :
- diuretics
- cathartics (laxatives)
- ipecac
Social History (SH) :
- discontentment with body weight and shape strongly related to frequency of reading fashion magazines in survey of preadolescent and adolescent girls, 47% reported wanting to lose weight because of magazine pictures (Pediatrics 1999 Mar;103(3):e36 full-text)
Review of Systems (ROS) :
- consider inflammatory bowel disease (Crohn's disease, ulcerative colitis), hypothalamic or pituitary tumor, cancer, depression, schizophrenia, hyperthyroidism, Addison's disease, autoimmune disease
- itching may be common, poorly understood, often resolves with weight gain (Br J Dermatol 1999 Mar;140(3):453), commentary can be found in Br J Dermatol 1999 Mar;140(3):453
- review of gynecologic effects of anorexia, bulimia and obesity in adolescents can be found in Am Fam Physician 2001 Aug 1;64(3):445 full-text, editorial can be found in Am Fam Physician 2001 Aug 1;64(3):367 full-text
General Physical :
- cachexia
- decreased vital signs (pulse, temperature, respiratory rate, blood pressure)
- lethargy (ominous sign)
- hyperactivity despite malnutrition (typical)
- reluctance to be weighed
- baggy and loose clothing may be worn to conceal thinness
- skimpy clothing may be worn to flaunt thin body
Skin :
- manifestations of anorexia nervosa associated malnutrition
- dry skin (common)
- lanugo hair (common)
- hair loss (common)
- hypercarotenemia (common)
- acrocyanosis (occasional)
- nail dystrophy (occasional)
- pellagra (rare)
- angular stomatitis - fissuring of corners of mouth (occasional)
- manifestations of anorexia nervosa associated behaviors
- cutting, burning or other signs of self-afflicted harm (common)
- hair pulling (trichotillomania) (occasional)
- rare cutaneous associations of anorexia nervosa
- acne
- chilblains
- pili torti - twisting hair shaft abnormality
- Reference - J Cutan Med Surg 2002 Jul-Aug;6(4):345 PDF
Extremities :
- peripheral edema suggests medical cause or severe malnutrition (hypoproteinemia)
Making the diagnosis :
- DSM-IV-TR criteria
- refusal to maintain weight over minimal normal leading to body weight 15% below expected
- intense fear of gaining weight or becoming fat even though underweight
- disturbance in image of weight or shape, undue influence of body weight or shape on self-evaluation, or denial of seriousness of current low body weight
- in females absence of at least 3 consecutive menstrual cycles
Rule out :
- inflammatory bowel disease (Crohn's disease, ulcerative colitis)
- hypothalamic or pituitary tumor
- cancer
- depression
- schizophrenia
- hyperthyroidism
- Addison's disease
- autoimmune disease
- disordered upper gastrointestinal motor activity may mimic anorexia nervosa
- based on study of esophageal motor activity in 30 consecutive patients meeting diagnostic criteria for primary anorexia nervosa
- 7 had achalasia
- 1 had diffuse esophageal spasm
- 1 had severe gastro-esophageal reflux and upper esophageal sphincter hypertonicity
- 6 had partly non-propulsive and repetitive high amplitude, long duration contractions in lower esophagus
- Reference - Gut 1986 Oct;27(10):1120
Testing to consider :
- check hCG in patients with amenorrhea
- blood tests
- CBC and differential
- electrolytes
- BUN
- creatinine
- glucose
- liver function tests
- total protein
- albumin
- thyroid function tests (TSH and T4)
- ECG
- bone density determination if amenorrhea > 6 months, or to establish baseline
- brain MRI in males with weight loss or atypical cases
Blood tests :
- pancytopenia is common
- electrolytes may be abnormal in cases of water intoxication, purging, laxative or diuretic abuse, or poor salt intake
- total protein and albumin may be decreased, serves as a marker of nutritional status, low or normal erythrocyte sedimentation rate (ESR)
- endocrine abnormalities (not necessary for diagnosis or treatment)
- typically decreased FSH, LH, T4 (mild), T3 (mild), estrone, and estradiol
- prepubertal levels of FSH and LH, no cyclic surge of LH
- typically increased cortisol, GH, rT3 and T3RU
- normal free T4 and TSH
Urine studies :
- decreased urinary 17-OH steroids
Imaging studies :
EKG :
Prognosis :
- variable, spontaneous remission common, may evolve to bulimia
- typical cases is chronic and relapsing
- anorexia nervosa often treatment-resistant but many patients recover
- 5-year clinical recovery rate 66.8%
- treatment dropout rates are high in anorexia nervosa
- treatments of anorexia nervosa complicated by high dropout rate
- based on randomized trial without clinical outcome
- 122 patients randomized to cognitive-behavioral therapy vs. fluoxetine vs. combination of both for 1 year
- 21 patients (17%) withdrawn, mainly due to treatment failure
- 56 remaining patients (55%) dropped out
- among 89 patients who accepted treatment, only predictor of treatment completion was high self-esteem (86% rate of treatment completion vs. 40% rate with low self-esteem)
- Reference - Arch Gen Psychiatry 2005 Jul;62(7):776
- comorbid psychiatric disorders, problematic family behaviors, and long term family therapy may be associated with higher dropout and lower rate of remission
- based on randomized trial comparing short-term vs. long-term family therapy
- lower rates or remission associated with comorbid psychiatric diagnoses, older age, and problematic family behaviors
- Reference - Int J Eat Disord 2006 Dec;39(8):639
- multiple studies report increased mortality rates in patients with anorexia nervosa
- 5.9% mortality associated with anorexia
- 3.2% 5-year mortality in prospective study
- based on prospective study of 216 patients with eating disorders followed for 5 years
- 3 (3.2%) of 95 with anorexia died
- 56% of anorexic patients had no diagnosable eating disorder at 5 years but treatment did not appear to be effective
- Reference - Lancet 2001 Apr 21;357(9264);1254 commentary can be found in Lancet 2001 Sep 15;358(9285):926
- mortality in patients with anorexia nervosa in Sweden has decreased from 1980 to 1990
- based on comparison of 2 cohorts in Sweden
- 564 patients born 1958-1967 and hospitalized for anorexia nervosa 1977-1981 were followed until 1992, during which time 25 (4.4%) died
- 554 patients born 1968-1977 and hospitalized for anorexia nervosa 1987-1991 were followed until 2002, during which time 7 (1.3%) died
- authors suggest that introduction of specialized care units may account for mortality difference
- Reference - Am J Psychiatry 2006 Aug;163(8):1433
- no long-term mortality increase reported in population-based community cohort
- 21-year follow-up of 84 patients with anorexia nervosa
- 51% had made full recovery
- 10% still met full diagnostic criteria for anorexia nervosa
- 16% had died from causes related to anorexia nervosa
- Reference - Lancet 2000 Feb 26;355(9205):721
- admitted patients tend to have continued treatment needs over subsequent years
- based on prospective study of 338 patients hospitalized for eating disorder
- 242 (72%) were followed for mean 6.4 years, 90% had anorexia nervosa, > 90% were female
- mean BMI 14.3 kg/m 2
- average patient had > 4 months total time of hospitalization and was in some kind of treatment for 30% of time over 6 years
- 50% required second hospitalization, 25% required third hospitalization
- 7 patients (3%) died as consequence of eating disorder
- 80% normalized weight, eating behavior and menstruation at follow-up
- Reference - Eur Child Adolesc Psychiatry 2003;12 Suppl 1:I91 in Pediatric Notes 2003 Jul 31;27(31):121)
- resolution of orthostatic pulse changes may take 3 weeks in patients admitted to hospital for anorexia nervosa
- based on retrospective study of 36 patients ages 12-23 years admitted for anorexia nervosa
- mean time to resolution of orthostatic pulse changes 21.6 days
- resolution of orthostatic pulse changes occurred upon attainment of 80% ideal body weight
- Reference - J Adolesc Health 2003 Jan;32(1):73
Treatment overview :
- consider hospitalization if weight < 75-85% ideal body weight or medical decompensation, but inpatient treatment does not appear more effective than outpatient treatment for initial treatment of anorexia nervosa in adolescents (level 2 [mid-level] evidence)
- limited evidence for behavioral treatment of anorexia nervosa
- most evidence in adolescents relates to family therapy
- counseling therapies with limited evidence of benefit in adults in single trials
- evidence for medications sparse and inconclusive
Diet :
- strict behavioral protocols may be needed to ensure weight gain
- American Dietetic Association recommendations for treatment of anorexia nervosa include
- gradual adjustments in nutrient intake and weight progress
- stepping up caloric intake from baseline level of 30-40 kilocalories/kg of weight per day (starting at 1,000- 1,200 kcal per day) to achieve a weight gain of 0.5-1 lbs (0.23-0.45 kg) per week
- eventual goal of nutritional rehabilitation is restoration of healthful weight and resumption of normal eating patterns
- Reference - J Am Diet Assoc 2006 Dec;106(12):2073
- complications of nutritional replacement include
- development of truncal obesity
- refeeding syndrome
- can precipitate cardiac failure related to hypophosphatemia
- usually occurs within 4 days of resuming feeding
- discussion of refeeding syndrome can be found in BMJ 2004 Apr 17;328(7445):908 full-text
Activity :
Counseling :
- limited evidence for behavioral treatment of anorexia nervosa
- based on systematic review
- AHRQ evidence-based review identified 17 behavioral intervention studies
- 6 studies considered poor quality and not discussed further
- 2 good-quality and 9 fair-quality trials summarized
- forms of family therapy appeared effective in 5 trials in adolescents and adults
- cognitive behavioral therapy may reduce relapse risk for adults after weight restoration, based on 1 trial
- focal analytic therapy reported to increase recovery or improvement rates in 1 trial in adults
- no benefit found in single trials of
- cognitive analytic therapy (2 trials in adults)
- dietary counseling in adults
- interpersonal psychotherapy in adults
- behavioral therapy in adults
- Reference - AHRQ Evidence Report on Management of Eating Disorders 2006 Apr:135
- family therapy might be associated with faster return to health than individual therapy in adolescents (level 2 [mid-level] evidence)
- based on 2 small randomized trials by same authors
- behavioral family systems therapy (family therapy) associated with faster return to health than ego-oriented individual therapy (individual therapy) (level 2 [mid-level] evidence)
- based on small randomized trial
- 37 adolescents with anorexia nervosa were randomized to family therapy vs. individual therapy
- family therapy included family seen conjointly, parents placed in control of adolescent's eating, distorted beliefs targeted through cognitive restructuring
- individual therapy group included adolescent seen individually, emphasis on building ego strength
- family therapy produced greater weight gain and higher rates of resumption of menstruation
- at 1 year follow-up both treatments had comparably large improvements in eating attitudes, depression, and eating-related family conflict
- Reference - J Am Acad Child Adolesc Psychiatry 1999 Dec;38(12):1482, commentary can be found in J Am Acad Child Adolesc Psychiatry 2001 Feb;40(2):129
- DynaMed commentary -- unclear if differences related to parental involvement or different psychologic approaches
- behavioral family systems therapy (family therapy) and ego-oriented individual therapy (individual therapy) had similar outcomes (level 2 [mid-level] evidence)
- based on small randomized trial
- 22 adolescents aged 12-19 years with anorexia nervosa and no bulimic features were randomized to family therapy vs. individual therapy for 16 months
- family therapy included parents placed in control of adolescent's eating, distorted beliefs targeted through cognitive therapy
- individual therapy group included individual patient counseling weekly and parental sessions twice monthly (with focus on parental education and encouragement of non-judgmental support)
- no significant differences between groups in eating attitudes and internalizing behaviors
- weight gain improved faster with family therapy, but conclusion limited by baseline differences
- Reference - J Dev Behav Pediatr 1994 Apr;15(2):111, Int J Eat Disord 1995 May;17(4):313
- different family therapy approaches appear to have similar efficacy in adolescents with anorexia nervosa (level 2 [mid-level] evidence)
- based on 3 randomized trials with 3 different comparisons
- conjoint family therapy and separated family therapy associated with similar outcomes (level 2 [mid-level] evidence)
- based on small randomized trial
- 40 adolescents with anorexia nervosa were randomized to conjoint family therapy vs. separated family therapy
- families were compared at baseline, 3 months, 6 months and end of treatment
- improvement in nutritional and psychological state reported in both groups with no significant differences between groups in global outcome measure
- Reference - J Child Psychol Psychiatry 2000 Sep;41(6):727
- family group psychoeducation and family therapy associated with similar outcomes (level 2 [mid-level] evidence)
- based on small randomized trial
- 25 females aged 12-17 years admitted for inpatient medical therapy of newly diagnosed restrictive eating disorder randomized to family group psychoeducation vs. family therapy every 2 weeks for 4 months (8 sessions)
- both groups had adequate weight gain but little to no impact on eating disorder psychopathology
- Reference - Can J Psychiatry 2000 Mar;45(2):173
- short-course family therapy (10 sessions over 6 months) and long-course family therapy (20 sessions over 12 months) had similar outcomes at 1 year and at 2-6 years (mean 4 years) (level 2 [mid-level] evidence) in randomized trial in 86 adolescents ages 12-18 years with anorexia nervosa (J Am Acad Child Adolesc Psychiatry 2005 Jul;44(7):632, J Am Acad Child Adolesc Psychiatry 2006 Jun;45(6):666)
- no strong evidence to guide individual psychotherapy for adults with anorexia nervosa; systematic review of 6 small randomized trials last updated 2003 Jul 14 (Cochrane Library 2003 Issue 4:CD003909)
- cognitive behavior therapy might reduce relapse rates after hospitalization for anorexia nervosa in adults (level 2 [mid-level] evidence)
- based on small randomized trial with non-significant trends
- 33 women aged 18-45 years following inpatient treatment for anorexia nervosa were randomized to cognitive behavior therapy vs. nutritional counseling for 50 individual sessions over 1 year
- cognitive behavior therapy focused on cognitive and behavioral features associated with eating pathology and used schema-based approach to address issues related to self-esteem, self-schema, and interpersonal functioning
- comparing cognitive behavior therapy vs. nutritional counseling
- 0 vs. 3 of 15 (20%) dropped out of therapy before 10 sessions completed
- 4 of 18 (22%) vs. 8 of 15 (53%) met criteria for relapse at 1 year (p < 0.06)
- 3 of 18 (17%) vs. 0 met criteria for full recovery at 1 year (p < 0.1)
- Reference -Am J Psychiatry 2003 Nov;160(11):2046 full-text
- specific cognitive behavior therapy and specific interpersonal psychotherapy may be no more effective than nonspecific supportive therapy for anorexia nervosa (level 2 [mid-level] evidence)
- based on small randomized trial with high dropout rate
- 56 women aged 17-40 years with anorexia nervosa were randomized to cognitive behavior therapy (specific for anorexia nervosa) vs. interpersonal psychotherapy (specific for anorexia nervosa) vs. nonspecific supportive clinical management (control) for 20 weekly sessions
- 38% dropout rate
- no significant differences in weight gain
- no significant differences in most individual outcomes, but control group had significantly better outcomes for some global measures
- Reference -Am J Psychiatry 2005 Apr;162(4):741 full-text
- focal psychotherapy or family therapy may modestly improve outcomes in adults (level 2 [mid-level] evidence)
- based on small randomized trial with high dropout rate
- 84 adults with anorexia nervosa randomized to focal psychoanalytic psychotherapy vs. family therapy vs. cognitive-analytic therapy vs. routine outpatient management without psychotherapy
- 36% dropout rate
- rates of any improvement at 1 year follow-up
- 38% (8 of 21) for focal psychotherapy
- 41% (9 of 22) for family therapy
- 32% (7 of 22) for cognitive analytic therapy
- 28% (5 of 19) for routine treatment
- differences from routine treatment were statistically significant for focal psychotherapy and family therapy
- Reference - Br J Psychiatry 2001 Mar;178:216 full-text, commentary can be found in Br J Psychiatry 2001 Jul;179:77 full-text
Medications :
- evidence for medications sparse and inconclusive
- based on systematic review
- AHRQ evidence-based review found 15 medication trials for anorexia nervosa
- 7 trials with poor quality were not discussed further
- 8 randomized double-blind trials included total 345 patients, only 1 trial explicitly reported intention-to-treat analysis
- none of 8 trials reported significant effect on weight gain
- trials limited by high dropout rates
- Reference - AHRQ Evidence Report on Management of Eating Disorders 2006 Apr:135
- antidepressants
- insufficient evidence regarding antidepressants for anorexia nervosa
- based on systematic review of 7 randomized trials of antidepressant treatment for patients with anorexia nervosa
- small trials and large confidence intervals limited ability to detect differences
- 4 placebo-controlled trials did not find evidence that antidepressants improved weight gain, eating disorder or associated psychopathology
- isolated findings favoring amineptine (Survector) and nortriptyline (Pamelor, Aventyl) were reported compared to other antidepressants
- Reference - systematic review last updated 2005 Nov 4 (Cochrane Library 2006 Issue 1:CD004365)
- fluoxetine (Prozac, Sarafem) not associated with improved outcomes in patients with anorexia nervosa (level 2 [mid-level] evidence)
- based on 2 randomized trials with high dropout rates
- fluoxetine (target dose 60 mg/day) for 7 weeks did not significantly affect weight gain, eating symptoms or depressive symptoms (level 2 [mid-level] evidence)
- fluoxetine following weight restoration not associated with relapse prevention or treatment retention (level 2 [mid-level] evidence)
- based on randomized trial with high dropout rate
- 93 patients with anorexia nervosa who regained weight to minimum body mass index 19 kg/m 2 were randomized to fluoxetine vs. placebo for up to 1 year, all patients received individual cognitive behavioral therapy
- no significant differences comparing fluoxetine vs. placebo
- 26.5% vs. 31.5% maintained body mass index at least 18.5 kg/m 2 and remained in study for 52 weeks
- 57% vs. 57% withdrew early due to patient-initiated withdrawals (14 vs. 13 cases), weight loss to body mass index ≤ 16.5 kg/m 2 (7 vs. 6 cases), depression (2 vs. 3 cases), clinical deterioration (1 vs. 1 case), and staff-initiated withdrawals (4 vs. 2 cases)
- 14.3% vs. 9.1% full recovery
- 57% vs. 55% relapse
- Reference - JAMA 2006 Jun 14;295(22):2605 (correction in JAMA 2006 Aug 23;296(8):934), correction can be found in JAMA 2007 Nov 7;298(17):2008, editorial can be found in JAMA 2006 Jun 14;295(22):2659, commentary can be found in JAMA 2006 Nov 22;296(20):2439
- citalopram (Celexa) may reduce depressive and other psychologic symptoms in anorexia nervosa (level 2 [mid-level] evidence)
- based on randomized trial with high dropout rate
- 52 female outpatients with restricting-type anorexia nervosa were randomized to citalopram vs. waiting list control for 3 months
- 13 patients (25%) dropped out
- citalopram associated with decreases in depression scores, obsessive-compulsive symptoms, impulsiveness and trait anger
- no significant differences in weight gain
- Reference - Eur Neuropsychopharmacol 2002 Oct;12(5):453
- tricyclic antidepressants lack evidence of efficacy for weight gain but not well studied
- augmentation of fluoxetine with nutritional supplements (tryptophan, vitamins, minerals and essential fatty acids) did not improve weight gain (level 2 [mid-level] evidence) in randomized placebo-controlled trial in 26 patients with anorexia nervosa (Int J Eat Disord 2004 Jan;35(1):10)
- atypical antipsychotics
- zinc supplementation associated with accelerated rate of weight gain (level 2 [mid-level] evidence)
- based on small randomized trial with high dropout rate
- 54 female inpatients with anorexia nervosa randomized to zinc gluconate 100 mg daily vs. placebo until 10% increase in body mass index
- 19 patients (35%) dropped out
- zinc group had higher rate of increase than placebo group (p = 0.03)
- Reference - Int J Eat Disord 1994 Apr;15(3):251
- zinc supplementation (50 mg elemental zinc/day) reported to reduce depression and anxiety levels in randomized placebo-controlled trial; mean zinc intake of anorectic adolescents 7.7 mg/day was lower than 15 mg recommended daily allowance (J Adolesc Health Care 1987 Sep;8(5):400)
- growth hormone therapy during inpatient treatment of anorexia nervosa may accelerate time to orthostatic stabilization (level 3 [lacking direct] evidence)
- based on small randomized trial without clinical outcome
- 15 females ages 12-18 years with DSM-IV diagnosis of anorexia nervosa and weight < 80% ideal body weight were admitted for standard treatment (including nasogastric tube feeding if not gaining 0.5 lb/day [0.23 kg/day])
- patients were randomized to recombinant human growth hormone 0.05 mg/kg vs. placebo subcutaneously once daily until discharged or for 28 days
- medical stability defined as absence of orthostasis (pulse increase > 20 beats/minute from supine to standing) on 2 consecutive mornings
- comparing growth hormone vs. placebo
- median time to medical stability was 17 days vs. 37 days (p = 0.02)
- median length of hospital stay 32 days vs. 39 days (not statistically significant)
- Reference - J Child Adolesc Psychopharmacol 2000 Spring;10(1):3
- testosterone might reduce severe depression in women with anorexia nervosa and testosterone deficiency (level 2 [mid-level] evidence)
- based on subgroup analysis of small randomized trial
- 33 women ages 18-50 years with anorexia nervosa and low testosterone levels were randomized to transdermal testosterone (Intrinsa) 150 mcg/day vs. 300 mcg/day vs. placebo for 3 weeks
- 18 women (54%) had severe depression (mean Beck Depression Inventory score 20) at baseline
- in depressed women, mean reduction in Beck Depression Inventory score about 5.3 with testosterone vs. 0.5 with placebo (p = 0.02)
- Reference - J Clin Endocrinol Metab 2005 Mar;90(3):1428 full-text
- oral contraceptive does not appear to protect against abnormal fat redistribution following refeeding in women with anorexia nervosa (level 2 [mid-level] evidence)
- based on small randomized trial
- 27 women randomized to oral contraceptive (ethinyl estradiol 35 mcg plus norethindrone 0.4 mg) vs. placebo while encouraged to gain weight for 9 months
- 10 women in each group gained weight with average of 4.1 kg
- change in percentage of trunk fat between estrogen treated group and placebo group not significant
- Reference - Am J Clin Nutr 2001 May;73(5):865 full-text, editorial can be found in Am J Clin Nutr 2001 May;73(5):851 full-text
- cyproheptadine (Periactin) not clearly useful in anorexia nervosa
- cisapride (Propulsid) 10 mg 3 times daily did not result in weight gain (level 2 [mid-level] evidence)
- lithium reported to increase weight but study inconclusive due to baseline differences (level 3 [lacking direct] evidence)
- based on small randomized trial with baseline differences
- 16 females aged 12-32 years admitted with DSM-IV diagnosis of anorexia nervosa were all treated with behavioral modification (group therapy weekly, individual therapy twice weekly, tube feedings as needed) and randomized to lithium carbonate (started at 300 mg daily and titrated by 300 mg/day to plasma lithium 0.9-1.4 mEq/L) vs. placebo for 4 weeks
- comparing lithium vs. placebo
- mean daily caloric intake at baseline 2,345 vs. 1,569
- mean baseline weight 35.7 kg vs. 32.7 kg (78.5 lbs vs. 71.9 lbs)
- mean weight at 4 weeks 42.5 kg vs. 37.9 kg (93.5 lbs vs. 83.4 lbs)
- mean weight gain at 4 weeks 6.8 kg vs. 5.2 kg (15 lbs vs. 11.4 lbs)
- Reference - J Clin Psychopharmacol 1981 Nov;1(6):376
- oral tetrahydrocannabinol (THC) does not appear effective for short-term weight gain in anorexia nervosa (level 2 [mid-level] evidence)
- based on small randomized crossover trial
- 11 females admitted for anorexia nervosa were randomized to oral THC 2.5 mg-10 mg 3 times daily in increasing doses vs. oral diazepam 1-5 mg 3 times daily in increasing doses (as active placebo) for 2 weeks each in crossover trial
- treatment also included behavior modification therapy, weekly group therapy, and tube feedings as necessary to maintain weight for 4 weeks
- comparing THC vs. diazepam, no significant differences were found in weight gain
- 3 patients experienced severe dysphoric reactions to the THC
- Reference - J Clin Psychopharmacol 1983 Jun;3(3):165
- treatment of complications
- limited evidence regarding treatments to prevent osteoporosis
- oral contraceptives (OCP) may not improve bone density in females with anorexia nervosa (level 3 [lacking direct] evidence)
- based on 3 randomized trials without clinical outcomes
- no significant differences between groups after 13 cycles (52 weeks) in randomized placebo-controlled trial of triphasic oral contraceptive (norgestimate 180-250 mcg plus ethinyl estradiol 35 mcg) in 112 girls aged 11-17 years with anorexia nervosa (J Adolesc Health 2006 Dec;39(6):819)
- no significant differences between groups receiving oral contraceptives and groups receiving placebo after 9 months in 4-way randomized placebo-controlled trial (also testing recombinant human insulin-like growth factor 1) in 60 women with anorexia nervosa (J Clin Endocrinol Metab 2002 Jun;87(6):2883 full-text)
- no significant difference between groups after mean 1.5 years in randomized placebo-controlled trial of oral contraceptives in 48 amenorrheic women with anorexia nervosa (J Clin Endocrinol Metab 1995 Mar;80(3):898)
- etidronate (Didrocal), or calcium plus vitamin D, each reported to improve bone mineral density (level 3 [lacking direct] evidence)
- based on randomized trial without clinical outcome
- 41 outpatients with restricting type of anorexia nervosa were randomized to etidronate vs. calcium and vitamin D vs. placebo for 3 months
- both active treatment groups reported to have statistically significant increases in bone mineral density using "tibial speed of sound" measurement compared to control
- Reference - Int J Eat Disord 2006 Jan;39(1):20
- alendronate (Fosamax) not shown to improve bone density compared to placebo in adolescents girls with anorexia nervosa (level 3 [lacking direct] evidence)
- oral dehydroepiandrosterone (DHEA) and hormonal replacement therapy (HRT) did not differ in effects on bone density in women with anorexia nervosa (level 3 [lacking direct] evidence)
- based on randomized trial without clinical outcome
- 61 females aged 14-28 years with anorexia nervosa were randomized to DHEA or HRT for 1 year
- bone mineral density (BMD) was measured at baseline, 6 months and 1 year
- both groups had mean weight gain over the year, with increase in the BMD being positively correlated to weight gain
- Reference - J Clin Endocrinol Metab 2002 Nov;87(11):4935 full-text
- phosphate supplementation has been suggested for patients with hypophosphatemia during first week of hospitalization for anorexia nervosa (grade C recommendation [lacking direct evidence])
- based on retrospective study of 69 patients admitted for anorexia nervosa
- 15 (22%) had mild hypophosphatemia (2.5-3 mg/dL [0.81-0.97 mmol/L])
- 4 (6%) had moderate hypophosphatemia (1-2.5 mg/dL [0.32-0.81 mmol/L])
- in this cohort, only complication was short runs of ventricular tachycardia in patient with lowest phosphorus levels
- however, hypophosphatemia may cause cardiac dysrhythmia, delirium, sudden death
- authors recommend checking phosphorus level daily and supplementing as needed
- Reference - J Adolesc Health 2003 Jan;32(1):83
Consultation and referral :
- treatment for anorexia nervosa is demanding and complex
- potentially useful consultants include
- psychiatrist specializing in treatment of eating disorders
- psychologist specializing in treatment of eating disorders
- dietitian
Other management :
Follow-up :
- maintain weight > 75% ideal body weight
- weight at resumption of menses varies
Prevention :
- no evidence to support programs to prevent eating disorders in children and adolescents; systematic review of 8 trials last updated 2002 Feb 8 (Cochrane Library 2002 Issue 2:CD002891)
- school-based intervention may reduce purging or using diet pills to control weight
- dissonance-inducing activities and healthy weight management prevention programs may reduce risk factors for eating disorders in adolescent girls
- 481 adolescent girls with body dissatisfaction randomized to 1 of 4 programs
- eating disorder prevention program with dissonance-inducing activities that reduce thin-ideal internalization
- prevention program promoting healthy weight management
- expressive writing control condition
- assessment-only control condition
- dissonance participants had significantly greater reductions in eating disorder risk factors and bulimic symptoms than 3 other groups
- dissonance and healthy weight participants had significantly lower binge eating and obesity onset and reduced service utilization through 12 months than other 2 groups
- Reference - J Consult Clin Psychol 2006 Apr;74(2):263
- internet program associated with improvement in body image and decrease in drive for thinness at 3 months (level 3 [lacking direct] evidence) in randomized trial in 60 college women (J Consult Clin Psychol 2000 Apr;68(2):346)
Screening :
- SCOFF acronym may be useful for screening for eating disorders
- 5 questions
- Do you make yourself Sick because you feel uncomfortably full?
- Do you worry you have lost Control over how much you eat?
- Have you recently lost Over 10 pounds in a 3 month period (original description was One stone = 14 pounds = 6.3 kg)?
- Do you believe yourself to be Fat when others say you are too thin?
- Would you say that Food dominates your life?
- 2 or more positive answers suggests eating disorder
- validation of this screening questionnaire done by comparing 116 women 18-40 with confirmed anorexia or bulimia in eating disorders clinic with 96 controls, so unknown if applicable to general population or younger women
- Reference - BMJ 1999 Dec 4;319(7223):1467 full-text
- SCOFF questionnaire had 85% sensitivity, 90% specificity, 24% positive predictive value and 99.3% negative predictive value for eating disorder in study of 341 women (BMJ 2002 Oct 5;325(7367):755 BMJ 2002 Oct 5;325(7367):755), correction can be found in BMJ 2002 Dec 7;325(7376):1331, commentary can be found in Evidence-Based Medicine 2003 May-Jun;8(3):90
- SCOFF screening tool equally effective when administered in oral or written format, based on 178 student volunteers completing both screening approaches in random order (Int J Eat Disord 2002 Dec;32(4):466)
General references used :
- systematic review including 32 studies of treatment of anorexia nervosa (AHRQ Evidence Report on Management of Eating Disorders 2006 Apr:135)
- Clinical Evidence 2004 Dec;12 (search date 2003 Dec)
- MEDLINE search 2007 Mar 6 using PubMed Clinical Queries (therapy) for anorexia nervosa
- Click here to repeat MEDLINE search
- 46 studies included in this summary
- Dunican KC, DelDotto D. The role of olanzapine in the treatment of anorexia nervosa. Ann Pharmacother. 2007 Jan;41(1):111-5.
- Strokosch GR, Friedman AJ, Wu SC, Kamin M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health. 2006 Dec;39(6):819-27.
- Richards PS, Berrett ME, Hardman RK, Eggett DL. Comparative efficacy of spirituality, cognitive, and emotional support groups for treating eating disorder inpatients. Eat Disord. 2006 Oct-Dec;14(5):401-15.
- Lock J, Couturier J, Bryson S, Agras S. Predictors of dropout and remission in family therapy for adolescent anorexia nervosa in a randomized clinical trial. Int J Eat Disord. 2006 Dec;39(8):639-47.
- Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC, Pike KM, Devlin MJ, Woodside B, Roberto CA, Rockert W. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA. 2006 Jun 14;295(22):2605-12.
- Nakahara T, Nagai N, Tanaka M, Muranaga T, Kojima S, Nozoe S, Naruo T. The effects of bone therapy on tibial bone loss in young women with anorexia nervosa. Int J Eat Disord. 2006 Jan;39(1):20-6.
- Halmi KA, Agras WS, Crow S, Mitchell J, Wilson GT, Bryson SW, Kraemer HC. Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs. Arch Gen Psychiatry. 2005 Jul;62(7):776-81.
- Lock J, Agras WS, Bryson S, Kraemer HC. A comparison of short- and long-term family therapy for adolescent anorexia nervosa. J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):632-9.
- McIntosh VV, Jordan J, Carter FA, Luty SE, McKenzie JM, Bulik CM, Frampton CM, Joyce PR. Three psychotherapies for anorexia nervosa: a randomized, controlled trial. Am J Psychiatry. 2005 Apr;162(4):741-7.
- Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005 Jun;90(6):3179-85.
- Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry. 2005 Mar;13(1):72-5.
- Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab. 2005 Mar;90(3):1428-33.
- Birmingham CL, Gutierrez E, Jonat L, Beumont P. Randomized controlled trial of warming in anorexia nervosa. Int J Eat Disord. 2004 Mar;35(2):234-8.
- Barbarich NC, McConaha CW, Halmi KA, Gendall K, Sunday SR, Gaskill J, La Via M, Frank GK, Brooks S, Plotnicov KH, Kaye WH. Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa. Int J Eat Disord. 2004 Jan;35(1):10-5.
- Pike KM, Walsh BT, Vitousek K, Wilson GT, Bauer J. Cognitive behavior therapy in the posthospitalization treatment of anorexia nervosa. Am J Psychiatry. 2003 Nov;160(11):2046-9.
- Jordan J, Joyce PR, Carter FA, Horn J, McIntosh VV, Luty SE, McKenzie JM, Mulder RT, Bulik CM. Anxiety and psychoactive substance use disorder comorbidity in anorexia nervosa or depression. Int J Eat Disord. 2003 Sep;34(2):211-9.
- Szabo CP, Green K. Hospitalized anorexics and resistance training: impact on body composition and psychological well-being. A preliminary study. Eat Weight Disord. 2002 Dec;7(4):293-7.
- Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab. 2002 Nov;87(11):4935-41.
- Perry L, Morgan J, Reid F, Brunton J, O'Brien A, Luck A, Lacey H. Screening for symptoms of eating disorders: reliability of the SCOFF screening tool with written compared to oral delivery. Int J Eat Disord. 2002 Dec;32(4):466-72.
- Fassino S, Leombruni P, Daga G, Brustolin A, Migliaretti G, Cavallo F, Rovera G. Efficacy of citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharmacol. 2002 Oct;12(5):453-9.
- Bergh C, Brodin U, Lindberg G, Sodersten P. Randomized controlled trial of a treatment for anorexia and bulimia nervosa. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9486-91.
- Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002 Jun;87(6):2883-91.
- Ruggiero GM, Laini V, Mauri MC, Ferrari VM, Clemente A, Lugo F, Mantero M, Redaelli G, Zappulli D, Cavagnini F. A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jul;25(5):1049-59.
- Grinspoon S, Thomas L, Miller K, Pitts S, Herzog D, Klibanski A. Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr. 2001 May;73(5):865-9.
- Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, Plotnicov KH, Weise J, Deep D. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001 Apr 1;49(7):644-52.
- Winzelberg AJ, Eppstein D, Eldredge KL, Wilfley D, Dasmahapatra R, Dev P, Taylor CB. Effectiveness of an Internet-based program for reducing risk factors for eating disorders. J Consult Clin Psychol. 2000 Apr;68(2):346-50.
- Hill K, Bucuvalas J, McClain C, Kryscio R, Martini RT, Alfaro MP, Maloney M. Pilot study of growth hormone administration during the refeeding of malnourished anorexia nervosa patients. J Child Adolesc Psychopharmacol. 2000 Spring;10(1):3-8.
- Geist R, Heinmaa M, Stephens D, Davis R, Katzman DK. Comparison of family therapy and family group psychoeducation in adolescents with anorexia nervosa. Can J Psychiatry. 2000 Mar;45(2):173-8.
- Ricca V, Mannucci E, Paionni A, Di Bernardo M, Cellini M, Cabras PL, Rotella CM. Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study. Eat Weight Disord. 1999 Mar;4(1):10-4.
- Robin AL, Siegel PT, Moye AW, Gilroy M, Dennis AB, Sikand A. A controlled comparison of family versus individual therapy for adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12):1482-9.
- Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry. 1998 Apr;155(4):548-51.
- Stacher G, Abatzi-Wenzel TA, Wiesnagrotzki S, Bergmann H, Schneider C, Gaupmann G. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Br J Psychiatry. 1993 Mar;162:398-402.
- Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord. 1994 Apr;15(3):251-5.
- Robin AL, Siegel PT, Koepke T, Moye AW, Tice S. Family therapy versus individual therapy for adolescent females with anorexia nervosa. J Dev Behav Pediatr. 1994 Apr;15(2):111-6.
- Davis C, Kennedy SH, Ravelski E, Dionne M. The role of physical activity in the development and maintenance of eating disorders. Psychol Med. 1994 Nov;24(4):957-67.
- Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995 Mar;80(3):898-904.
- Szmukler GI, Young GP, Miller G, Lichtenstein M, Binns DS. A controlled trial of cisapride in anorexia nervosa. Int J Eat Disord. 1995 May;17(4):347-57.
- Robin AL, Siegel PT, Moye A. Family versus individual therapy for anorexia: impact on family conflict. Int J Eat Disord. 1995 May;17(4):313-22.
- Lacey JH, Crisp AH. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J. 1980;56 Suppl 1:79-85.
- Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee LE, Kaye WH. A double-blind controlled trial of lithium carbonate primary anorexia nervosa. J Clin Psychopharmacol. 1981 Nov;1(6):376-81.
- Halmi KA, Eckert E, Falk JR. Cyproheptadine for anorexia nervosa. Lancet. 1982 Jun 12;1(8285):1357-8.
- Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 1985 Feb;5(1):10-6.
- Halmi KA, Eckert E, LaDu TJ, Cohen J. Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry. 1986 Feb;43(2):177-81.
- Gross H, Ebert MH, Faden VB, Goldberg SC, Kaye WH, Caine ED, Hawks R, Zinberg N. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol. 1983 Jun;3(3):165-71.
- Eckert ED, Goldberg SC, Halmi KA, Casper RC, Davis JM. Behaviour therapy in anorexia nervosa. Br J Psychiatry. 1979 Jan;134:55-9.
- Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM. Cyproheptadine in anorexia nervosa. Br J Psychiatry. 1979 Jan;134:67-70.
- 14 studies included in summarized systematic reviews
- Dare C, Eisler I, Russell G, Treasure J, Dodge L. Psychological therapies for adults with anorexia nervosa: randomised controlled trial of out-patient treatments. Br J Psychiatry. 2001 Mar;178:216-21.
- Eisler I, Dare C, Hodes M, Russell G, Dodge E, Le Grange D. Family therapy for adolescent anorexia nervosa: the results of a controlled comparison of two family interventions. J Child Psychol Psychiatry. 2000 Sep;41(6):727-36.
- Thien V, Thomas A, Markin D, Birmingham CL. Pilot study of a graded exercise program for the treatment of anorexia nervosa. Int J Eat Disord. 2000 Jul;28(1):101-6.
- Bachar E, Latzer Y, Kreitler S, Berry EM. Empirical comparison of two psychological therapies. Self psychology and cognitive orientation in the treatment of anorexia and bulimia. J Psychother Pract Res. 1999 Spring;8(2):115-28.
- Eisler I, Dare C, Russell GF, Szmukler G, le Grange D, Dodge E. Family and individual therapy in anorexia nervosa. A 5-year follow-up. Arch Gen Psychiatry. 1997 Nov;54(11):1025-30.
- Treasure J, Todd G, Brolly M, Tiller J, Nehmed A, Denman F. A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav Res Ther. 1995 May;33(4):363-7.
- Gowers S, Norton K, Halek C, Crisp AH. Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. Int J Eat Disord. 1994 Mar;15(2):165-77.
- Killen JD, Taylor CB, Hammer LD, Litt I, Wilson DM, Rich T, Hayward C, Simmonds B, Kraemer H, Varady A. An attempt to modify unhealthful eating attitudes and weight regulation practices of young adolescent girls. Int J Eat Disord. 1993 May;13(4):369-84.
- Stacher G, Kiss A, Wiesnagrotzki S, Bergmann H, Hobart J, Schneider C. Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa. Gut. 1986 Oct;27(10):1120-6.
- Hall A, Crisp AH. Brief psychotherapy in the treatment of anorexia nervosa. Outcome at one year. Br J Psychiatry. 1987 Aug;151:185-91.
- Russell GF, Szmukler GI, Dare C, Eisler I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry. 1987 Dec;44(12):1047-56.
- Katz RL, Keen CL, Litt IF, Hurley LS, Kellams-Harrison KM, Glader LJ. Zinc deficiency in anorexia nervosa. J Adolesc Health Care. 1987 Sep;8(5):400-6.
- Channon S, de Silva P, Hemsley D, Perkins R. A controlled trial of cognitive-behavioural and behavioural treatment of anorexia nervosa. Behav Res Ther. 1989;27(5):529-35.
- Crisp AH, Norton K, Gowers S, Halek C, Bowyer C, Yeldham D, Levett G, Bhat A. A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. Br J Psychiatry. 1991 Sep;159:325-33.
- 75 studies not included in this summary
- Stice E, Presnell K, Gau J, Shaw H. Testing mediators of intervention effects in randomized controlled trials: An evaluation of two eating disorder prevention programs. J Consult Clin Psychol. 2007 Feb;75(1):20-32.
- Godart N, Perdereau F, Rein Z, Curt F, Kaganski I, Lucet R, Corcos M, Fermanian J, Flament M, Jeammet P. Resolving a disagreement in a clinical team: overcoming conflicting views about the role of family therapy in an outpatient treatment programme for anorexia nervosa. Eat Weight Disord. 2006 Dec;11(4):185-94.
- Birmingham CL, Gritzner S. How does zinc supplementation benefit anorexia nervosa? Eat Weight Disord. 2006 Dec;11(4):e109-11.
- Mondelli V, Gianotti L, Picu A, Abbate Daga G, Giordano R, Berardelli R, Pariante CM, Fassino S, Ghigo E, Arvat E. Neuroendocrine effects of citalopram infusion in anorexia nervosa. Psychoneuroendocrinology. 2006 Nov;31(10):1139-48.
- Chantler I, Szabo CP, Green K. Muscular strength changes in hospitalized anorexic patients after an eight week resistance training program. Int J Sports Med. 2006 Aug;27(8):660-5.
- Thomas JJ, Judge AM, Brownell KD, Vartanian LR. Evaluating the effects of eating disorder memoirs on readers' eating attitudes and behaviors. Int J Eat Disord. 2006 Jul;39(5):418-25.
- Rausch Herscovici C. [Lunch session, weight gain and their interaction with the psychopathology of anorexia nervosa in adolescents] Vertex. 2006 Jan-Feb;17(65):7-15.
- Winter TA, O'Keefe SJ, Callanan M, Marks T. The effect of severe undernutrition and subsequent refeeding on whole-body metabolism and protein synthesis in human subjects. JPEN J Parenter Enteral Nutr. 2005 Jul-Aug;29(4):221-8.
- Suslow T, Ohrmann P, Lalee-Mentzel J, Donges US, Arolt V, Kersting A. Incidental learning of food and emotional words in women with anorexia nervosa. Eat Weight Disord. 2004 Dec;9(4):290-5.
- Constantino MJ, Arnow BA, Blasey C, Agras WS. The association between patient characteristics and the therapeutic alliance in cognitive-behavioral and interpersonal therapy for bulimia nervosa. J Consult Clin Psychol. 2005 Apr;73(2):203-11.
- Miller KK, Deckersbach T, Rauch SL, Fischman AJ, Grieco KA, Herzog DB, Klibanski A. Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa. Psychiatry Res. 2004 Dec 30;132(3):197-207.
- Mohammadi MR, Ghanizadeh A, Alaghband-Rad J, Tehranidoost M, Mesgarpour B, Soori H. Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial. J Child Adolesc Psychopharmacol. 2004 Fall;14(3):418-25.
- Grinspoon S, Miller KK, Herzog DB, Grieco KA, Klibanski A. Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab. 2004 Aug;89(8):3988-93.
- Stice E, Fisher M, Martinez E. Eating disorder diagnostic scale: additional evidence of reliability and validity. Psychol Assess. 2004 Mar;16(1):60-71.
- McDermott C, Agras WS, Crow SJ, Halmi K, Mitchell JE, Bryson S. Participant recruitment for an anorexia nervosa treatment study. Int J Eat Disord. 2004 Jan;35(1):33-41.
- Pallanti S, Quercioli L, Ramacciotti A. Citalopram in anorexia nervosa. Eat Weight Disord. 1997 Dec;2(4):216-21.
- Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab. 2003 Aug;88(8):3989-92.
- Garcia-Garcia E, Vazquez-Velazquez V, Lopez-Alvarenga JC, Arcila-Martinez D. [Internal validity and diagnostic utility of the Eating Disorder Inventory in Mexican women] Salud Publica Mex. 2003 May-Jun;45(3):206-10.
- Bergh C, Ejderhamn J, Sodersten P. What is the evidence basis for existing treatments of eating disorders? Curr Opin Pediatr. 2003 Jun;15(3):344-5.
- Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, McConaha CW, Kishore A. Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. Int J Eat Disord. 2003 Apr;33(3):257-67;
- Grinspoon S, Miller K, Herzog D, Clemmons D, Klibanski A. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. J Clin Endocrinol Metab. 2003 Mar;88(3):1142-9.
- Hoyt WD, Hamilton SB, Rickard KM. The effects of dietary fat and caloric content on the body-size estimates of Anorexic Profile and normal college students. J Clin Psychol. 2003 Jan;59(1):85-91.
- Eiber R, Berlin I, de Brettes B, Foulon C, Guelfi JD. Hedonic response to sucrose solutions and the fear of weight gain in patients with eating disorders. Psychiatry Res. 2002 Dec 15;113(1-2):173-80.
- Monteleone P, Brambilla F, Bortolotti F, Maj M. Serotonergic dysfunction across the eating disorders: relationship to eating behaviour, purging behaviour, nutritional status and general psychopathology. Psychol Med. 2000 Sep;30(5):1099-110.
- Drobes DJ, Miller EJ, Hillman CH, Bradley MM, Cuthbert BN, Lang PJ. Food deprivation and emotional reactions to food cues: implications for eating disorders. Biol Psychol. 2001 Jul-Aug;57(1-3):153-77.
- Frank GK, Kaye WH, Weltzin TE, Perel J, Moss H, McConaha C, Pollice C. Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration. Int J Eat Disord. 2001 Jul;30(1):57-68.
- Gianotti L, Fassino S, Daga GA, Lanfranco F, De Bacco C, Ramunni J, Arvat E, MacCario M, Ghigo E. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. Clin Endocrinol (Oxf). 2000 Jun;52(6):713-20.
- Gendall KA, Bulik CM, Sullivan PF, Joyce PR, Mcintosh VV, Carter FA. Body weight in bulimia nervosa. Eat Weight Disord. 1999 Dec;4(4):157-64.
- Birmingham CL, Muller JL, Goldner EM. Randomized trial of measures of body fat versus body weight in the treatment of anorexia nervosa. Eat Weight Disord. 1998 Jun;3(2):84-9.
- De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Milardi D, Mascadri C, Giustina A. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa. Metabolism. 2000 Feb;49(2):155-9.
- Kachele H. [A multicenter study of expenditure and success in psychodynamic therapy of eating disorders. Study design and initial results] Psychother Psychosom Med Psychol. 1999 Mar-Apr;49(3-4):100-8.
- Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res. 1999 Jan;14(1):136-45.
- Brambilla F, Bellodi L, Brunetta M, Perna G. Plasma concentrations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in anorexia and bulimia nervosa. Psychoneuroendocrinology. 1998 Jul;23(5):439-47.
- Monteleone P, Brambilla F, Bortolotti F, La Rocca A, Maj M. Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa. Br J Psychiatry. 1998 May;172:439-42.
- Laumer U, Bauer M, Fichter M, Milz H. [Therapeutic effects of the Feldenkrais method "awareness through movement" in patients with eating disorders] Psychother Psychosom Med Psychol. 1997 May;47(5):170-80.
- Giusti M, Foppiani L, Ponzani P, Cuttica CM, Falivene MR, Valenti S. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. J Endocrinol Invest. 1997 May;20(5):257-63.
- Marrazzi MA, Wroblewski JM, Kinzie J, Luby ED. High-dose naltrexone and liver function safety. Am J Addict. 1997 Winter;6(1):21-9.
- Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab. 1996 Nov;81(11):3864-70.
- Sullivan PF, Bulik CM, Carter FA, Gendall KA, Joyce PR. The significance of a prior history of anorexia in bulimia nervosa. Int J Eat Disord. 1996 Nov;20(3):253-61.
- Foppiani L, Sessarego P, Valenti S, Falivene MR, Cuttica CM, Giusti Disem M. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa. Eur J Clin Invest. 1996 Oct;26(10):879-83.
- Andrewes DG, O'Connor P, Mulder C, McLennan J, Derham H, Weigall S, Say S. Computerised psychoeducation for patients with eating disorders. Aust N Z J Psychiatry. 1996 Aug;30(4):492-7.
- Cole-Detke H, Kobak R. Attachment processes in eating disorder and depression. J Consult Clin Psychol. 1996 Apr;64(2):282-90.
- Brambilla F, Brunetta M, Peirone A, Perna G, Sacerdote P, Manfredi B, Panerai AE. T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Res. 1995 Nov 29;59(1-2):43-50.
- Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res. 1996 Apr 16;62(1):31-42.
- Dancyger IF, Garfinkel PE. The relationship of partial syndrome eating disorders to anorexia nervosa and bulimia nervosa. Psychol Med. 1995 Sep;25(5):1019-25.
- Overduin J, Jansen A, Louwerse E. Stroop interference and food intake. Int J Eat Disord. 1995 Nov;18(3):277-85.
- Fairburn CG, Jones R, Peveler RC, Hope RA, O'Connor M. Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Arch Gen Psychiatry. 1993 Jun;50(6):419-28.
- Rossiter EM, Agras WS, Telch CF, Schneider JA. Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa. Int J Eat Disord. 1993 May;13(4):349-57.
- De Marinis L, Mancini A, Fiumara C, Conte G, Iacona T, Ianiri L, Zeppetelli E, Gobbi G, Tempesta E. Growth hormone response to growth hormone-releasing hormone in early abstinent alcoholic patients. Psychoneuroendocrinology. 1993;18(7):475-83.
- Kling MA, Demitrack MA, Whitfield HJ Jr, Kalogeras KT, Listwak SJ, DeBellis MD, Chrousos GP, Gold PW, Brandt HA. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients. Neuroendocrinology. 1993 Jun;57(6):1082-91.
- Castillo MJ, Scheen AJ, Jandrain B, Lefebvre PJ. Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. Int J Obes Relat Metab Disord. 1994 Jan;18(1):47-53.
- Ghigo E, Arvat E, Gianotti L, Nicolosi M, Valetto MR, Avagnina S, Bellitti D, Rolla M, Muller EE, Camanni F. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol Psychiatry. 1994 Nov 15;36(10):689-95.
- Franko DL, Wolfe BE, Jimerson DC. Elevated sweet taste pleasantness ratings in bulimia nervosa. Physiol Behav. 1994 Nov;56(5):969-73.
- Hergenroeder AC. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr. 1995 May;126(5 Pt 1):683-9.
- Fairburn CG, Norman PA, Welch SL, O'Connor ME, Doll HA, Peveler RC. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry. 1995 Apr;52(4):304-12.
- Hadigan CM, Walsh BT, Buttinger C, Hollander E. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. Biol Psychiatry. 1995 Apr 15;37(8):504-11.
- Consolazio CF, Johnson HL, Krzywicki HJ, Daws TA. Metabolic aspects of acute altitude exposure (4,300 meters) in adequately nourished humans. Am J Clin Nutr. 1972 Jan;25(1):23-9.
- Silbert MV. The weight gain effect of periactin in anorexic patients. S Afr Med J. 1971 Apr 3;45(14):374-7.
- Wilson AJ, Touyz SW, O'Connor M, Beumont PJ. Correcting the eating disorder in anorexia nervosa. J Psychiatr Res. 1985;19(2-3):449-51.
- Freeman C, Sinclair F, Turnbull J, Annandale A. Psychotherapy for bulimia: a controlled study. J Psychiatr Res. 1985;19(2-3):373-8.
- Robinson PH, Checkley SA, Russell GF. Suppression of eating by fenfluramine in patients with bulimia nervosa. Br J Psychiatry. 1985 Feb;146:169-76.
- Stacher G, Bergmann H, Wiesnagrotzki S, Kiss A, Schneider C, Mittelbach G, Gaupmann G, Hobart J. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology. 1987 Apr;92(4):1000-6.
- Telian SA, Handler SD, Fleisher GR, Baranak CC, Wetmore RF, Potsic WP. The effect of antibiotic therapy on recovery after tonsillectomy in children. A controlled study. Arch Otolaryngol Head Neck Surg. 1986 Jun;112(6):610-5.
- Wilson GT, Rossiter E, Kleifield EI, Lindholm L. Cognitive-behavioral treatment of bulimia nervosa: a controlled evaluation. Behav Res Ther. 1986;24(3):277-88.
- Casanueva FF, Borras CG, Burguera B, Muruais C, Fernandez M, Devesa J. Steroids and neuroendocrine function in anorexia nervosa. J Steroid Biochem. 1987;27(1-3):635-40.
- Casanueva FF, Borras CG, Burguera B, Lima L, Muruais C, Tresguerres JA, Devesa J. Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers. Clin Endocrinol (Oxf). 1987 Nov;27(5):517-23.
- Lauer C, Krieg JC, Zulley J, Riemann D, Berger M. [Sleep in anorexia nervosa, bulimia nervosa and depressive diseases: a polysomnographic comparative study] Fortschr Neurol Psychiatr. 1989 Oct;57(10):403-10.
- Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry. 1990 Feb;47(2):149-57.
- Safai-Kutti S. Oral zinc supplementation in anorexia nervosa. Acta Psychiatr Scand Suppl. 1990;361:14-7.
- Bearn JA, Fairhall KM, Robinson IC, Lightman SL, Checkley SA. Changes in a proposed new neuroendocrine marker of oestrogen receptor function in postpartum women. Psychol Med. 1990 Nov;20(4):779-83.
- Lauer CJ, Krieg JC, Riemann D, Zulley J, Berger M. A polysomnographic study in young psychiatric inpatients: major depression, anorexia nervosa, bulimia nervosa. J Affect Disord. 1990 Apr;18(4):235-45.
- Mizes JS. Construct validity and factor stability of the anorectic cognitions questionnaire. Addict Behav. 1991;16(1-2):89-93.
- Stacher G, Bergmann H, Granser-Vacariu GV, Wiesnagrotzki S, Wenzelabatzi TA, Gaupmann G, Kugi A, Steinringer H, Schneider C, Hobart J. Lack of systematic effects of the 5-hydroxytryptamine 3 receptor antagonist ICS 205-930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa. Br J Clin Pharmacol. 1991 Dec;32(6):685-9.
- Mizes JS. The body image detection device versus subjective measures of weight dissatisfaction: a validity comparison. Addict Behav. 1992;17(2):125-36.
- Walker J, Roberts SL, Halmi KA, Goldberg SC. Caloric requirements for weight gain in anorexia nervosa. Am J Clin Nutr. 1979 Jul;32(7):1396-1400.
- 1 awaiting full-text evaluation
Reviews :
- review can be found in BMJ 2007 Apr 28;334(7599):894
- review can be found in N Engl J Med 2005 Oct 6;353(14):1481
- review can be found in Am Fam Physician 1996 Sep 15;54(4):1273
- editorial review can be found in BMJ 2004 Feb 28;328(7438):479 full-text, commentary can be found in BMJ 2004 May 1;328(7447):1075 full-text, BMJ 2004 May 1;328(7447):1075 full-text
- review of treating eating disorders in primary care can be found in Am Fam Physician 2008 Jan 15;77(2):187 full-text
- review of eating disorders in primary care can be found in Adv Stud Med 2004 Oct;4(9):468 PDF
- review of eating disorders in primary care can be found in Am Fam Physician 2003 Jan 15;67(2):297 full-text, commentary can be found in Am Fam Physician 2003 Jul 1;68(1):41 full-text
- review of eating disorders can be found in N Engl J Med 1999 Apr 8;340(14):1092 (Am Fam Physician 1999 Oct 15;60(6):1816), commentary can be found in N Engl J Med 1999 Aug 19;341(8):614
- review of eating disorders can be found in Lancet 2003 Feb 1;361(9355):407, commentary can be found in Lancet 2003 May 31;361(9372):1913
- review of eating disorders in children can be found in Pediatrics 2003 Jan;111(1):e98 full-text
- review can be found in Aust Fam Physician 2000 Apr;29(4):328 (Am Fam Physician 2000 Oct 1;62(7):1680)
- review can be found in Ann Intern Med 2001 Jun 5;134(11):1048 PDF, summary can be found in Am Fam Physician 2002 Feb 1;65(3):478
- review of eating disorders in adolescence can be found in Aust Fam Physician 2004 Jan-Feb;33(1-2):27 PDF
- review of eating disorders in pregnancy can be found in BMJ 2008 Jan 12;336(7635):93, correction can be found in BMJ 2008 Jan 19;336(7636)
- review of the female athlete triad (eating disorder, amenorrhea and osteoporosis) can be found in Am Fam Physician 2000 Jun 1;61(11):3357 full-text
- review of female athlete triad (osteoporosis, disordered eating, menstrual disorders) can be found in BMJ 2005 Jan 29;330(7485):244 full-text
- case presentation can be found in N Engl J Med 2008 Sep 18;359(12):1272
- case presentation in older woman can be found in Clin Geriatr 2004 Oct;12(10):25
- review of psychopharmacological, psychosocial and combined interventions for childhood disorders from American Psychological Association Working group on Psychotropic Medications for Children and Adolescents 2006 Aug PDF
Guidelines :
- synthesis of 4 guidelines (AAP 2003, APA 2006, Finnish Medical Society Duodecim 2007, NCCMH/NICE 2004) on management of eating disorders can be found at National Guideline Clearinghouse 2008 Feb 25:EATING_DISORDERS1
- American Psychiatric Association (APA) practice guidelines for treatment of patients with eating disorders can be found at National Guideline Clearinghouse 2006 Aug 21:9318 or at APA PDF, previous version can be found in Am J Psychiatry 2000 Jan;157(suppl):1, summary can be found in Am Fam Physician 2000 Jul 1;62(1):185
- NICE guideline on eating disorders (core interventions in treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders) can be found at NICE 2004 Jan:CG9 or at National Guideline Clearinghouse 2005 Apr 4:5066
- comparison of National Institute for Clinical Excellence (NICE) evidence-based guidelines with American Psychiatric Association (APA) guidelines (considered uncritical) can be found in Lancet 2005 Jan 1;365(9453):79
- AAP policy statement on eating disorders can be found in Pediatrics 2003 Jan;111(1):204 full-text or at National Guideline Clearinghouse 2003 Jul 28:3589, summary can be found in Am Fam Physician 2003 May 15;67(10):2224 full-text
- Finnish Medical Society Duodecim evidence-based guidelines on eating disorders among children and adolescents can be found at National Guideline Clearinghouse 2008 Jan 14:11035
- Australian and New Zealand clinical practice guidelines for the treatment of anorexia nervosa can be found in Aust N Z J Psychiatry 2004 Sep;38(9):659, correction can be found in Aust N Z J Psychiatry 2004 Nov-Dec;38(11-12):987, commentary can be found in Aust N Z J Psychiatry 2005 Jul;39(7):639
- AAP statement on Medical Concerns in the Female Athlete can be found in Pediatrics 2000 Sep;106(3):610 full-text, commentary can be found in Pediatrics 2002 Feb;109(2):350 full-text
- American Academy of Pediatrics (AAP) policy statement on promotion of healthy weight-control practices in young athletes can be found in Pediatrics 2005 Dec;116(6):1557 full-text, correction can be found in Pediatrics 2006 Apr;117(4):1467, can also be found at National Guideline Clearinghouse 2006 Apr 24:8452, summary can be found in Am Fam Physician 2006 Jun 1;73(11):2069
- American Dietetic Association (ADA) position paper on nutrition intervention in treatment of anorexia nervosa, bulimia nervosa and other eating disorders can be found in J Am Diet Assoc 2006 Dec;106(12):2073
- American Dietetic Association (ADA) evidence-based nutrition practice guideline on critical illness can be found at ADA
- American Society for Parenteral and Enteral Nutrition (ASPEN) guidelines on nutrition support for adults with specific diseases and conditions can be found in J Parenter Enteral Nutr 1993 Jul/Aug;17(4 Suppl):12SA
Patient information :
|
|